BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
EQS
Equus Total Return, Inc.
There isn't enough reported data to score EQS yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
EQS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| N/A | |
| N/A |
EQS's profitability is currently under pressure. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like EQS.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
EQS PE Valuation
EQS has no meaningful PE right now: it lost money over the past year.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
EQS Forward outlook
There aren't enough analyst estimates for EQS to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over EQS on earnings quality, reporting a profit while its opponent remains loss making.
EQS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.36 | -$0.12 |
| Q1 2026 | -$1.04 | -$0.10 |
| Q4 2025 | -$1.03 | +$0.33 |
| Q3 2025 | -$1.13 | -$0.63 |
| Q2 2025 | -$1.24 | -272% |
| Q1 2025 | -$0.94 | -208% |
| Q4 2024 | -$1.36 | -242% |
| Q3 2024 | -$0.50 | -162% |
EQS lost $1.36 per share over the past year, about the same as its loss the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the stronger quarterly revenue trend. Revenue is up 6.7% for BAC versus down 29% for EQS.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over EQS on profitability, with a higher operating margin.
EQS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2021 | $1.4M | -58% |
EQS's revenue is shrinking: $990,000 last quarter, down 29% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -455% | N/A |
| Q1 2026 | 78% | N/A |
| Q4 2021 | 15% | N/A |
| Q3 2021 | 67% | N/A |
| Q2 2021 | 46% | -31 points |
| Q1 2021 | 23% | N/A |
| Q2 2020 | 77% | N/A |
| Q3 2019 | 52% | N/A |
EQS's operating margin was −455% last quarter, down 501 points from the same quarter a year ago, near the bottom of its range since 2019.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the stronger cash trend. Its trailing FCF is up 119% versus its history, compared with EQS at down 275%.
EQS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | $7K | +$1.6M |
| Q4 2025 | -$196K | -100% |
| Q1 2025 | -$1.6M | +$9.8M |
| Q4 2024 | $53.6M | +$87.5M |
| Q3 2024 | -$1.8M | +$5.9M |
| Q2 2024 | -$2.1M | +$2.1M |
| Q1 2024 | -$11.4M | -$5.9M |
| Q4 2023 | -$33.9M | -$31.1M |
EQS's free cash flow was −$7M over the past year, against $38M the year before. Free cash flow isn't a meaningful measure for financial services companies like EQS.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over EQS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
EQS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -19% | -3.3M shares |
| 1 year | +2.8% | +381K shares |
| 3 years | +3.3% | +449K shares |
| 5 years | +3.3% | +449K shares |
| Available history | +3.3% | +449K shares |
EQS has 14M diluted shares, up 2.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
EQS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2021 | -8.0x | Net Cash |
| Q4 2019 | 7.7x | High |
| Q3 2019 | 6.9x | High |
EQS has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like EQS.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
EQS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 26.5 | Oversold |
| Stochastic | 6.9 | Oversold |
EQS's weekly RSI is 26 (oversold) and its Stochastic is 7 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
EQS PE vs Financial Services Sector
| Metric | EQS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
EQS has no meaningful PE right now: it lost money over the past year.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has the edge over EQS on trend strength, trading above more of its moving averages.
EQS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.78 | 31% below |
| 20 week MA | $0.98 | 45% below |
| 50 week MA | $1.26 | 57% below |
| 100 week MA | $1.36 | 60% below |
| 200 week MA | $1.41 | 62% below |
EQS is in a downtrend: it's below all five of its weekly moving averages, and 62% below its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over EQS on returns for 2026, with the stronger performance.
EQS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.67 | $2.18 | +31% |
| 2021 | $2.18 | $2.36 | +8.3% |
| 2022 | $2.36 | $1.63 | -31% |
| 2023 | $1.63 | $1.45 | -11% |
| 2024 | $1.45 | $1.10 | -24% |
| 2025 | $1.10 | $1.66 | +51% |
| 2026 YTD | $1.66 | $0.54 | -67% |
EQS has finished lower in three of the last six years. It's down 67% so far in 2026.